Literature DB >> 25037260

Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies.

Peter S Lee1, Ian A Wilson.   

Abstract

Influenza hemagglutinin (HA) is the major surface glycoprotein on influenza viruses and mediates viral attachment and subsequent fusion with host cells. The HA is the major target of the immune response, but due to its high level of variability, as evidenced by substantial antigenic diversity, it had been historically considered to elicit only a narrow, strain-specific antibody response. However, a recent explosion in the discovery of broadly neutralizing antibodies (bnAbs) to influenza virus has identified two major supersites of vulnerability on the HA through structural characterization of HA-antibody complexes. These commonly targeted epitopes are involved with receptor binding as well as the fusion machinery and, hence, are functionally conserved and less prone to mutation. These bnAbs can neutralize viruses by blocking infection or the spread of infection by preventing progeny release. Structural analyses of these bnAbs show they exhibit striking similarities and trends in recognition of the HA and use recurring recognition motifs, despite substantial differences in their germline genes. This information can be utilized in design of novel therapeutics as well as in immunogens for improved vaccines with greater breadth and efficacy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25037260      PMCID: PMC4358778          DOI: 10.1007/82_2014_413

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  66 in total

1.  A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site.

Authors:  D Fleury; B Barrère; T Bizebard; R S Daniels; J J Skehel; M Knossow
Journal:  Nat Struct Biol       Date:  1999-06

2.  Oseltamivir resistance during treatment of influenza A (H5N1) infection.

Authors:  Menno D de Jong; Tan Thanh Tran; Huu Khanh Truong; Minh Hien Vo; Gavin J D Smith; Vinh Chau Nguyen; Van Cam Bach; Tu Qui Phan; Quang Ha Do; Yi Guan; J S Malik Peiris; Tinh Hien Tran; Jeremy Farrar
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

3.  The annual impact of seasonal influenza in the US: measuring disease burden and costs.

Authors:  Noelle-Angelique M Molinari; Ismael R Ortega-Sanchez; Mark L Messonnier; William W Thompson; Pascale M Wortley; Eric Weintraub; Carolyn B Bridges
Journal:  Vaccine       Date:  2007-04-20       Impact factor: 3.641

4.  'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization.

Authors:  J B Ridgway; L G Presta; P Carter
Journal:  Protein Eng       Date:  1996-07

5.  Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation.

Authors:  J Chen; K H Lee; D A Steinhauer; D J Stevens; J J Skehel; D C Wiley
Journal:  Cell       Date:  1998-10-30       Impact factor: 41.582

6.  Antigen distortion allows influenza virus to escape neutralization.

Authors:  D Fleury; S A Wharton; J J Skehel; M Knossow; T Bizebard
Journal:  Nat Struct Biol       Date:  1998-02

7.  Studies of the binding properties of influenza hemagglutinin receptor-site mutants.

Authors:  J Martín; S A Wharton; Y P Lin; D K Takemoto; J J Skehel; D C Wiley; D A Steinhauer
Journal:  Virology       Date:  1998-02-01       Impact factor: 3.616

8.  Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.

Authors:  Rick A Bright; David K Shay; Bo Shu; Nancy J Cox; Alexander I Klimov
Journal:  JAMA       Date:  2006-02-02       Impact factor: 56.272

9.  Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies.

Authors:  Arun K Kashyap; John Steel; Ahmet F Oner; Michael A Dillon; Ryann E Swale; Katherine M Wall; Kimberly J Perry; Aleksandr Faynboym; Mahmut Ilhan; Michael Horowitz; Lawrence Horowitz; Peter Palese; Ramesh R Bhatt; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

10.  Structure of influenza haemagglutinin at the pH of membrane fusion.

Authors:  P A Bullough; F M Hughson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1994-09-01       Impact factor: 49.962

View more
  60 in total

1.  A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans.

Authors:  Devin Sok; Matthias Pauthner; Bryan Briney; Jeong Hyun Lee; Karen L Saye-Francisco; Jessica Hsueh; Alejandra Ramos; Khoa M Le; Meaghan Jones; Joseph G Jardine; Raiza Bastidas; Anita Sarkar; Chi-Hui Liang; Sachin S Shivatare; Chung-Yi Wu; William R Schief; Chi-Huey Wong; Ian A Wilson; Andrew B Ward; Jiang Zhu; Pascal Poignard; Dennis R Burton
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

2.  A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice.

Authors:  Alec W Freyn; Jamile Ramos da Silva; Victoria C Rosado; Carly M Bliss; Matthew Pine; Barbara L Mui; Ying K Tam; Thomas D Madden; Luís Carlos de Souza Ferreira; Drew Weissman; Florian Krammer; Lynda Coughlan; Peter Palese; Norbert Pardi; Raffael Nachbagauer
Journal:  Mol Ther       Date:  2020-04-19       Impact factor: 11.454

3.  Diversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.

Authors:  Nicholas C Wu; Jia Xie; Tianqing Zheng; Corwin M Nycholat; Geramie Grande; James C Paulson; Richard A Lerner; Ian A Wilson
Journal:  Cell Host Microbe       Date:  2017-06-14       Impact factor: 21.023

4.  Structure of the apo anti-influenza CH65 Fab.

Authors:  Peter S Lee; Ashley J Arnell; Ian A Wilson
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-01-28       Impact factor: 1.056

Review 5.  Influenza virus antigenicity and broadly neutralizing epitopes.

Authors:  Gillian M Air
Journal:  Curr Opin Virol       Date:  2015-04-04       Impact factor: 7.090

Review 6.  Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design.

Authors:  James E Crowe
Journal:  Cell Host Microbe       Date:  2017-08-09       Impact factor: 21.023

7.  Determinants of VH1-46 Cross-Reactivity to Pemphigus Vulgaris Autoantigen Desmoglein 3 and Rotavirus Antigen VP6.

Authors:  Michael Jeffrey Cho; Christoph T Ellebrecht; Christoph M Hammers; Eric M Mukherjee; Gopal Sapparapu; Crystal E Boudreaux; Sarah M McDonald; James E Crowe; Aimee S Payne
Journal:  J Immunol       Date:  2016-07-11       Impact factor: 5.422

8.  Antibody Determinants of Influenza Immunity.

Authors:  James E Crowe
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

Review 9.  Subdominance in Antibody Responses: Implications for Vaccine Development.

Authors:  Gunnar Lindahl
Journal:  Microbiol Mol Biol Rev       Date:  2020-11-25       Impact factor: 11.056

Review 10.  Structural insights into the design of novel anti-influenza therapies.

Authors:  Nicholas C Wu; Ian A Wilson
Journal:  Nat Struct Mol Biol       Date:  2018-02-02       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.